Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kojiro Tashiro

Showing results (31-40 of 96) with videos related to

Pageof 10
Sort By:
International Journal of Clinical Oncology|February 22, 2023
Comparison of outcomes in high-risk prostate cancer patients treated with low-/high-dose-rate brachytherapy plus external beam radiotherapyYu Imai, Fumihiko Urabe, Kosuke Iwatani, et al.
The Prostate|April 19, 2019
Differential expression of androgen receptor variants in hormone-sensitive prostate cancer xenografts, castration-resistant sublines, and patient specimens according to the treatment sequenceMariko Honda, Takahiro Kimura, Yuko Kamata, et al.
Case Reports in Urology|April 28, 2026
Intermittent Arterial Hemorrhage From Ureteral-Arterial Fistula After Long-Term Ureteral StentingKentaro Yoshihara, Kojiro Tashiro, Maria Okamoto, et al.
The Prostate|December 16, 2021
Clinical significance of unfavorable findings in intermediate-risk prostate cancer patients for predicting treatment outcomes after contemporary, dose-escalated multimodal radiotherapyFumihiko Urabe, Kenta Miki, Takahiro Kimura, et al.
International Cancer Conference Journal|March 31, 2025
A case of remarkable response to combined radiation therapy, enfortumab vedotin, and pembrolizumab in metastatic urothelial carcinomaFumihiko Urabe, Keigo Sakanaka, Mana Nakata, et al.
Translational Andrology and Urology|September 8, 2023
Presurgical immune-oncology/tyrosine kinase inhibitor combination therapy for renal cell carcinoma with a vena cava tumor thrombus: a single-institution case seriesFumihiko Urabe, Kosuke Iwatani, Masaki Hashimoto, et al.
Japanese Journal of Clinical Oncology|April 21, 2026
Prognostic impact of large cribriform architecture and intraductal carcinoma of the prostate in diagnostic biopsies of mCSPC receiving ARPI-based therapyShun Sato, Fumihiko Urabe, Yu Imai, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|February 8, 2025
Isepamicin alone as antimicrobial prophylaxis for transrectal prostate needle biopsy: "Do we still need levofloxacin? "Hiroki Yamada, Kojiro Tashiro, Yusuke Takahashi, et al.
Anticancer Research|September 29, 2023
The Efficacy and Safety of a Low Relative Dose Intensity of Cabazitaxel in Patients With Metastatic Castration-resistant Prostate CancerFumihiko Urabe, Daigo Kobayashi, Kosuke Iwatani, et al.
Translational Andrology and Urology|October 22, 2024
Optimizing prostate cancer detection in transition zone: an analysis of apparent diffusion coefficient values in prostate magnetic resonance imaging evaluation with Prostate Imaging Reporting and Data System (PI-RADS) assessmentYu Imai, Fumihiko Urabe, Ibuki Sadakane, et al.
Pageof 10

Showing results (31-40 of 96) with videos related to

Sort By:
Pageof 10
International Journal of Clinical Oncology|February 22, 2023
Comparison of outcomes in high-risk prostate cancer patients treated with low-/high-dose-rate brachytherapy plus external beam radiotherapyYu Imai, Fumihiko Urabe, Kosuke Iwatani, et al.
The Prostate|April 19, 2019
Differential expression of androgen receptor variants in hormone-sensitive prostate cancer xenografts, castration-resistant sublines, and patient specimens according to the treatment sequenceMariko Honda, Takahiro Kimura, Yuko Kamata, et al.
Case Reports in Urology|April 28, 2026
Intermittent Arterial Hemorrhage From Ureteral-Arterial Fistula After Long-Term Ureteral StentingKentaro Yoshihara, Kojiro Tashiro, Maria Okamoto, et al.
The Prostate|December 16, 2021
Clinical significance of unfavorable findings in intermediate-risk prostate cancer patients for predicting treatment outcomes after contemporary, dose-escalated multimodal radiotherapyFumihiko Urabe, Kenta Miki, Takahiro Kimura, et al.
International Cancer Conference Journal|March 31, 2025
A case of remarkable response to combined radiation therapy, enfortumab vedotin, and pembrolizumab in metastatic urothelial carcinomaFumihiko Urabe, Keigo Sakanaka, Mana Nakata, et al.
Translational Andrology and Urology|September 8, 2023
Presurgical immune-oncology/tyrosine kinase inhibitor combination therapy for renal cell carcinoma with a vena cava tumor thrombus: a single-institution case seriesFumihiko Urabe, Kosuke Iwatani, Masaki Hashimoto, et al.
Japanese Journal of Clinical Oncology|April 21, 2026
Prognostic impact of large cribriform architecture and intraductal carcinoma of the prostate in diagnostic biopsies of mCSPC receiving ARPI-based therapyShun Sato, Fumihiko Urabe, Yu Imai, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|February 8, 2025
Isepamicin alone as antimicrobial prophylaxis for transrectal prostate needle biopsy: "Do we still need levofloxacin? "Hiroki Yamada, Kojiro Tashiro, Yusuke Takahashi, et al.
Anticancer Research|September 29, 2023
The Efficacy and Safety of a Low Relative Dose Intensity of Cabazitaxel in Patients With Metastatic Castration-resistant Prostate CancerFumihiko Urabe, Daigo Kobayashi, Kosuke Iwatani, et al.
Translational Andrology and Urology|October 22, 2024
Optimizing prostate cancer detection in transition zone: an analysis of apparent diffusion coefficient values in prostate magnetic resonance imaging evaluation with Prostate Imaging Reporting and Data System (PI-RADS) assessmentYu Imai, Fumihiko Urabe, Ibuki Sadakane, et al.
Pageof 10